Navidea Biopharmaceuticals Inc Beta
Quel est le Beta de Navidea Biopharmaceuticals Inc?
Le Beta de Navidea Biopharmaceuticals Inc est 0.00
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NYSEMKT par rapport à Navidea Biopharmaceuticals Inc
Que fait Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Entreprises avec beta similaire à Navidea Biopharmaceuticals Inc
- Vision Marine Technologies a Beta de 0.00
- Ely Gold Royalties a Beta de 0.00
- Glacier Lake Resources a Beta de 0.00
- Magnum Mining and Exploration a Beta de 0.00
- Africa Opportunity Fund a Beta de 0.00
- Fulcrum Utility Services a Beta de 0.00
- Navidea Biopharmaceuticals Inc a Beta de 0.00
- Gullewa a Beta de 0.00
- S.A.L. Steel a Beta de 0.00
- Andina Acquisition III a Beta de 0.00
- Andina Acquisition III a Beta de 0.00
- Brilliant Acquisition a Beta de 0.00
- Indokem a Beta de 0.00